Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 3.51 1.74% 0.06
KALA closed up 1.74 percent on Monday, October 14, 2019, on 59 percent of normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical KALA trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.74%
Outside Day Range Expansion 1.74%
Wide Bands Range Expansion 1.74%
Oversold Stochastic Weakness 1.74%

Older signals for KALA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
KALA Chart by TradingView
Basic chart:
Profile
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Medicine Medical Specialties Pain Organ Systems Macular Degeneration Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Post Surgical Ocular Inflammation
Is KALA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 11 What Kind Of Shareholders Own Kala Pharmaceuticals, Inc. (NASDAQ:KALA)?
Sep 25 Implied Volatility Surging for Kala Pharmaceuticals (KALA) Stock Options
Aug 29 Kala Still Has A Shot To Reach Its Goal For Approval After Latest Setback
Aug 29 Kala Pharmaceuticals to Present at Two Upcoming Investor Conferences in September
Aug 27 A Holistic Look At Kala Pharmaceuticals, Inc. (NASDAQ:KALA)
Aug 23 Keep Your Eye on These 4 Healthcare Stocks
Aug 19 Should You Buy These 3 Beaten-Down Stocks Now?
Aug 16 The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission
Aug 12 The Market Is Sour On Kala Pharmaceuticals Despite Insider Support
Aug 12 90 Biggest Movers From Friday
See more KALA news...
Indicators
Indicator Value
52 Week High 10.21
52 Week Low 3.25
Average Volume 328,469
200-Day Moving Average 6.0545
50-Day Moving Average 4.1194
20-Day Moving Average 4.0275
10-Day Moving Average 3.738
Average True Range 0.2623
ADX 29.09
+DI 15.0316
-DI 32.3468
Chandelier Exit (Long, 3 ATRs ) 3.893
Chandelier Exit (Short, 3 ATRs ) 4.0369
Upper Bollinger Band 4.7719
Lower Bollinger Band 3.2831
Percent B (%b) 0.15
BandWidth 36.96586
MACD Line -0.1967
MACD Signal Line -0.1486
MACD Histogram -0.048
Fundamentals Value
Market Cap 85.04 Million
Num Shares 24.2 Million
EPS -32.85
Price-to-Earnings (P/E) Ratio -0.11
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.96
Resistance 3 (R3) 3.92 3.74 3.89
Resistance 2 (R2) 3.74 3.62 3.76 3.86
Resistance 1 (R1) 3.62 3.55 3.53 3.66 3.83
Pivot Point 3.44 3.44 3.39 3.46 3.44
Support 1 (S1) 3.32 3.32 3.23 3.36 3.19
Support 2 (S2) 3.14 3.25 3.16 3.16
Support 3 (S3) 3.02 3.14 3.14
Support 4 (S4) 3.06